POZ - News : Study Says HIV Fight Is In Your Genes
Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » News » July 2007

Web Exclusives

Evaluating the Costs of Earlier HIV Treatment

HIV Prevention Gets “Fergalicious”

Changing the HIV Treatment Paradigm

» More

Most Talked About

Magic Johnson Accused of Faking HIV (41)

The POZ/DDF Ratio (blog) (30)

Guidelines Prediction: Start Treatment Earlier (blog) (16)

HIV-Positive People Living Longer Than Ever Before (14)

Bone Marrow Transplant: Potential AIDS Cure? (8)

Obama Campaign Set to Boost Domestic HIV/AIDS Funding (8)

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from CancerWEB's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Herpes Simplex Virus

Human Papilloma Virus (HPV)

Shingles

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

10 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailrssprint

July 24, 2007

Study Says HIV Fight Is In Your Genes

Some people seem to have a genetic advantage in suppressing their HIV viral load and progressing more slowly to AIDS, according to a new study published July 19 online by the journal Science.

An international team of researchers from the Center for HIV/AIDS Vaccine Immunology (CHAVI) identified three gene variants in the DNA of 486 people infected with HIV. They found that patients with specific gene variants in certain immune system cells appear to be much better at controlling the spread of the virus after infection.

"These results not only approximately double our understanding of the factors that influence variation amongst individuals in how they control HIV-1, but also point toward new mechanisms of control," said lead researcher David Goldstein, Ph.D., of Duke University in a press release issued by Duke University.

This was the first genome-wide approach ever used for studying infectious disease. Goldstein says he hopes that it will help “design better treatments and more effective vaccines.”

emailrssprint


[Go to top]


Get Started
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Talk to Us
Weekly Poll
Question: Would legalizing prostitution reduce the spread of HIV?
Yes
No
I don't know.

Monthly Poll
Question: Do you believe that prisoners receive adequate health care?
Yes
No
I don't know.

Surveys
Tell us about your overall health habits.

Tell us when and to whom you disclose your status.

more surveys
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy